2024-03-05 14:41:06 ET
Compugen Ltd. (CGEN)
Q4 2023 Earnings Conference Call
March 05, 2024, 8:30 AM ET
Company Participants
Yvonne Naughton - Head of Investor Relations and Corporate Communications
Anat Cohen-Dayag - President and Chief Executive Officer
Alberto Sessa - Chief Financial Officer
Eran Ophir - Chief Scientific Officer
Michelle Mahler - Chief Medical Officer
Conference Call Participants
Asthika Goonewardene - Truist Securities
Daina Graybosch - Leerink Partners
Stephen Willey - Stifel
Presentation
Operator
Ladies and gentlemen, thank you for joining us today. Welcome to Compugen's Fourth Quarter and Full Year 2023 Results Conference Call. At this time, all participants are in a listen-only mode. An audio webcast of this call is available in the Investors section of Compugen's website www.cgen.com. As a reminder, today's call is being recorded.
I would now like to introduce Yvonne Naughton, Head of Investor Relations and Corporate Communication. Yvonne, please go ahead.
Yvonne Naughton
Thank you, operator, and thank you all for joining us on the call today. Joining me from Compugen for the prepared remarks are Dr. Anat Cohen-Dayag, President and Chief Executive Officer; and Alberto Sessa, Chief Financial Officer; Dr. Michelle Mahler, Chief Medical Officer; and Dr. Eran Ophir, Chief Scientific Officer, will join us for the Q&A.
Before we begin, we would like to remind you that during this call, the company may make projections or forward-looking statements regarding future events, business outlook, development efforts and the potential outcome, the company's discovery platform, anticipated progress and plans, results and time lines for our programs, financial and accounting related matters as well as statements regarding our cash position....
Read the full article on Seeking Alpha
For further details see:
Compugen Ltd. (CGEN) Q4 2023 Earnings Call Transcript